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Biopsies of involved and uninvolved skin from five patients 
w ith plaque psoriasis and normal skin from four healthy 
volunteers were investigated for steady-state quantities of 
TGF-alpha RNA and protein by in situ hybridization and 
immunohistochemistry. Increased levels ofTGF-alpha RNA 
were found only in the high-level keratinocytes of involved 
psoriatic skin (p < 0.001) . Elevated levels ofTGF-alpha pro-
P soriasis is a common benign hyperproliferative skin dis-ease, characterized by an abnormal pattern of keratino-cyte growth and differentiation, invasion of an inflam-matory infiltrate into both the dermis and epidermis, and morphologic changes in the dermal capillary net-
work [ 1]. The molecular etiology of the disease is not understood, 
though cytokines mediating their response via protein kinase C 
have been hypothesized to alter the growth characteristics of psoria-
tic keratinocytes [2] . The transforming growth factors are known to 
regulate both keratinocyte growth and differentiation [3] and TGF-
alpha, which is rresent in normal adult epidermis [4], is elevated in 
the epidermis o psoriatic plaques [5]. Here we show by a combina-
tion of in situ hybridization and immunohistochemistry that the 
elevated expression of TGF-alfha RNA is localized specifically to 
the high-level keratinocytes o the epidermis in psoriatic plaques. 
Transforming growth factor-alpha (TGF-alpha) is a 50-amino 
acid polypeptide which is involved in the regulation of both growth 
and differentiation of epithelial cells [ 6]. It is a structural homologue 
of epidermal growth factor (EGF) and effects its responses via the 
EGF receptor. In psoriatic skin EGF receptors are present in all 
viable layers of the epidermis as compared to normal skin where 
rhey are mainly restricted to the basal and parabasallayers [7,8] . This 
loss of EGF receptor down-regulation in differentiating psoriatic 
keratinocytes is accompanied by an increase in the numbers of cells 
replicating DNA in the basal and immediately suprabasal layers. 
Uninvolved psoriatic epidermis also shows some persistent expres-
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tein were seen in both the high-level and basal layers of 
involved psoriatic skin compared to uninvolved psoriatic and 
normal control skin. Elevated TGF-alpha gene expression is 
thus implicated in the hyperproliferation of keratinocytes 
and possibly the altered maturation pattern seen in psoriasis.] 
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sion of EGF receptors in the upper layers without a rise in the 
proportion of cells replicating DNA. Alterations in cytokine levels 
in addition to abnormalities in the distribution of the receptor may 
contribute to hyperproliferation of the involved psoriatic epidermis. 
MATERIALS AND METHODS 
We have investigated skin samples from five patients with chronic 
plaque psoriasis. All patients had used only topical yellow soft paraf-
fin on their psoriatic plaques, for at least one month prior to biopsy. 
Paired samples of involved and uninvolved psoriatic skin from these 
patients and four samples from normal healthy volunteers were 
obtained by full-thickness skin punch biopsy under local lignocaine 
anesthesia. All biopsies were taken from the same general area of the 
body. These were fixed in fresh 4% paraformaldehyde and paraffin 
processed. Approval from the Glasgow Western Infirmary Ethical 
Committee was obtained prior to the study. 
In situ hybridization was performed on 5-Jl paraffin sections 
using a human T<?~-al~ha riboprube, labeled with Jss. Riboprobe 
synthesis and hybndization was performed according to the method 
previously descnbed [9]. The TGF-alpha antisense probe was gener-
ated fr~m a 1.5-kb cD~A pr<;>be and inserted in the pSp65 vector in 
the anti-sense onentation With respe.ct to the SP6 promoter. This 
plasmid was kmdly supplied by Dr. Rik Derynk [10]. Hybridization 
was carried out at 5?oC overnight followed by high-stringency 
washes (50% formamide, 2 X SSC at 65oC) and RNase A digestion 
for 30 min at 37oC. Autoradiographic exposures (IIford K5 emul-
sion) were for? d (f<;>r grain counti~g) or 14 d. After development, 
slides were stamed 111 haematoxylm and eosin and mounted. All 
TGF-a lpha hybridizations were controlled by hybridization on se-
rial section~ with a labeled human ~horionic gonadotrophin ribo-
probe or With a TGF-alpha sense nboprobe. Hybridizations were 
also carried out with riboprobes to human Harvey ras* and beta-
actin (11] . 
Immunohistochemistry was performed on paraffin sections of 
involved and uninvolved psoriatic skin. Sections were cut and 
stained with anti-human TGF-alpha (mouse monoclonal to human 
* B Ballieux and A. Balmain (personal communication). 
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Figure 1. Localization of TGF-alpha expression in histologic sections of skin by in situ hybridization. TGF-alpha localized by in situ hybridization 
demonstrating ~ackground levels only i~ (A) normal skin and (B) uninvolved psor~atic skin. Elevated expression of TGF-alpha mRNA is shown in the 
high-level keratmocytes of mvolvcd psonatlc sbn (C). Control probe hybndtzed co mvolved psonattc sbn is shown in (D). 
TGF-alpha, with no cross reactivity to .EGF, kindly supplied. by 
Oncogene Science, Inc.) or normal rabbit serum and the PAP Im-
munoperoxidase technique as previ~u~ly ~escribed _[12]. 
Quantification of the in situ hybnd1zatwn expenments was car-
ried out. Three areas of psoriatic skin were chosen, namely, high-
level, suprabasal, and basal, and two areas of uninvolved ski~1, high-
level and basal. The numbers of silver grains in 5 helds of 
30 X 60 flm were counted for each area. Deposited silver grains 
were counted by image analysis using a Vickers microscope (X 100 
magnification under oil) linked to a video camera. The image was 
digitized on a Matrox 1512 board through a Compaq 386 computer 
running the Semper 6 programme (Synopt1cs, Ltd.). The numb~r of 
cells in each field was counted and the results calculated as grams/ 
cell. Statistical analysis using t tests were carried out on all data. 
RESULTS 
Increased expression of TGF-alpha mRNA was observed in the 
high-level keratinocytes, but not those in the mid or lower epi-
dermis, of all five involved psoriatic skins examined when in situ 
hybridization was carried out using an 35S-labeled riboprobe for 
transforming growth factor-alpha (Fig 1). Levels of hybridization 
to skin biopsies from the four normal individuals and from unin-
volved areas of the five patients. were the same as those obtained 
with a non-hybridizing control probe (human chorionic gonado-
trophin and TGF-alpha sense probes). It is possible that the strin-
gency conditions used in the hybridization procedure did not dis-
criminate between small levels of TGF-alpha mRNA, which have 
been reported in normal skin [4], and non-specific background. No 
TGF-alpha mRNA was detected over the dermal infiltrate or endo-
thelial cells. 
T.he in situ hybridization results were quantitated by image pro-
cessmg, calculated on a. grains/cell basis (Table I). This approach 
accounts for changes in keratinocyte volume in the various layers of 
the epidermis as cells differentiate and also for differences in cell size 
between involved and uninvolved psoriatic skin. Riboprobes com-
plementary to the human Harvey ras oncogene (eDNA from A. 
Balmain) and to human beta-actin were also used to control for the 
possibility that increased localization in the upper layers was due to 
condensation of the cytoplasm. Neither probe showed elevated 
levels of expression in the subcorneallayer (data not shown). The 
quantitation shows statistically significant differences (p < 0.001) 
ofTGF-alpha hybridization between the sub-corneal layer and the 
other areas in all five involved psoriatic skin hybridized with TGF-
alpha (see Table I). No significant differences in these comparative 
areas were found in uninvolved psoriatic or control skins. 
Immunohistochemistry using an anti-TGF-alpha antibody dem-
onstrated increased levels ofTGF-alpha polypeptide in the subcor-
neallayers of involved psoriatic skin compared to that in the unin-
volved regions, corresponding to those having elevated RNA. 
There was also localization of TGF-alpha polypeptide in the basal 
keratinocyte layer in both involved and uninvolved skin (Fig 2). 
In addition to keratinocyte localization ofTGF-alpha, the dermal 
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Table I. Results of Grain Counting of 6-d Exposures of In Sutu Hybridization• 
Ratios 
Psoriatics High Level (a) Suprabasal (b) Basal (c) a/b a/c 
1. involved 28.92 ± 3.9 5.53 ± 0.6 4.16 ± 0.7 5.23 6.95b 
uninvolved 5.5 ± 0.7 4.58 ± 0.7 1.2 
2. involved 27.36 ± 4.4 6.8 ± 0.9 5.98 ± 0.5 4.02 4.6b 
uninvolved 8.07 ± 0.9 6.78 ± 0.9 1.19 
3. involved 23.7 ± 3.4 6.25 ± 1.1 4.7 ± 0.5 3.8 5.0b 
uninvolved 8.9 ± 0.8 5.0 ± 0.4 1.76 
4. involved 19.74 ± 2.1 4.3 ± 0.7 6.25 ± 0.2 4.17 3.16b 
uninvolved 4.24 ± 0.8 3.2 ± 0.4 1.3 
5. involved 22.6 ± 3.0 5.6 ± 0.6 3.1 ± 0.7 4.1 7.29b 
uninvolved 6.3 ± 1.5 4.28 ± 0.5 1.47 
Controls 
1. Normal skin 3.48 ± 1.3 2.54 ± 0.5 1.37 
2. Normal skin 8.3 ± 0.5 7.46 ± 0.5 1.1 
3. Normal skin 7.49 ± 0.8 5.7 ± 0.5 1.31 
4. Normal skin 6.12 ± 0.8 4.85 ± 0.4 1.26 
• Total number of silver gra ins in five fields, each 30 X 6011, were counted in each area of skin, as were the totalnumberof cells in each field. The mean number of grains/cells± 1 
SO is shown. Ratios of th e numbers seen in each area arc also shown. 
' Statistically significant by student t test at p < 0.001 . 
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Figure 2. Localization ofTGF-alpha protein expression in paraffin sections 
of skin by immunohistochemistry. TGF-alpha polypeptide localized by im-
munoperoxidase in (A) the basal cel ls of uninvolved psoriatic skin and (B) the 
high-level keratinocytes of involved psoriatic skin. 
infiltrate and endothel ial cells also gave positive staining with anti-
TGF-alpha antibody in involved skin which is similar to the obser-
vations made by Gottlieb et al ( 13 J. 
DISCUSSION 
Our results confirm and extend the findings of Elder et a.l (5]. who 
showed by quantitative Northern and slot blot analysis that TGF-
alpha RNA levels are elevated fourfold to sixfold in involved psor-
iatic plaques compared to uninvolved or normal skin. In addition, 
our experiments show conclusively that the cell type predominantly 
responsible for elevated TGF-alpha production in the psoriatic 
plaque is the keratinocyte and not a dermal component, such as 
macrophages present in an epidermal preparation as ·a contaminant. 
Furthermore, there is a distinct regional distribution in those kerati-
nocytes overproducing TGF-alpha, with both basal and subcorneal 
layers over-expressing this protein. We did not observe an elevation 
in steady-state TGF-alpha RNA levels in basal psoriatic keratino-
cytes, suggesting that translational or post-translational control 
mechanisms act differentially in psoriatic basal keratinocytes com-
pared to subcorneal cell s. 
TGF-alpha is known to stimulate keratinocyte growth in vitro 
(4 , 14]. The more ubiquitous distribution ofEGF receptors found in 
involved and uninvolved psoriatic skin (7,8] provides one mecha-
nism whereby increased TGF-alpha levels could stimulate prolifer-
ation of keratinocytes. In fact, data of Nanney et al (8] shows ele-
vated EGF receptor levels specifically in the subcorneal cells where 
we see elevated TGF-alpha levels. However, the correlation be-
tween EGF receptor distribution and cell proliferation is not com-
plete, dividing keratinocytes being limited only to the first 2-3 cell 
layers of the stratum basalis. It is possible that the primary role of 
TGF-alpha produced in the subcorneallayer may be in altering the 
cellular differentiation pattern of the suprabasal layer, rather than 
acting as a mitogen, though it could also act in a paracrine manner 
on the basal keratinocytes. It is interesting to consider that in psoria-
tic plaques TGF-alpha produced by the two keratinocyte types, 
basal and high level, may serve different functions, the former in 
promoting hyperplasia in the latter in modulating differentiation. It 
is not possible to tell from this study whether the TGF-alpha de-
tected is in the secreted or membrane form (15]: the site of action of 
TGF-alpha cou ld be altered by this difference in molecular process-
mg. 
Psoriasis is characterized not only by abnormalities in the growth 
and differentiation of keratinocytes but also by alterations in the 
characteristics of many other cell types. The multiple activities of 
TGF-alpha, recognized as a potent angiogenic factor and inducer of 
232 TURBITT ET AL 
inflammation, could be responsible for many of the histologic and 
clinical features of psoriasis. 
Some of the known stimuli of the Koebner [ 11) (such as friction, 
burns, and wounding) that induce plaque formation in uninvolved 
psoriatic skin are also known to stimulate TGF-alpha synthesis [16]. 
A localized increase in TGF-alpha, which is known to be auto-stim-
ulatory [4), together with the ubiquitous distribution ofEGF recep-
tors in involved psoriatic skin could disturb the homeostatic regula-
tion of growth-factor production. In addition, it· is most probable 
that other growth factors are involved in the homeostatic regulation 
of keratinocyte growth and differentiation [18). An imbalance in 
expression of these cytokines, whether or not consequential to ele-
vated TGF-alpha gene expression, may also contribute to the patho-
genesis of this disease. 
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